Intralesional Bleomycin for Warts: Patient Satisfaction and Treatment Outcomes.
BACKGROUND
The treatment of warts is challenging with regards to both tolerability and efficacy.


OBJECTIVE
Ascertain the efficacy, tolerability, and patient satisfaction of intralesional bleomycin in the treatment of warts.


METHODS
Retrospective chart review followed by telephone interviews with patients from university-based dermatology referral centers.


RESULTS
Seventy-four percent (34/46) of patients had complete resolution (CR) of all warts. Of 34 patients who experienced CR, an average of 1.7 treatments were required. Pain experienced during the procedure and recovery, irrespective of outcome, was rated 5.8 out of 10 (range, 1-10; SD, 2.72; SEM, 0.40). Approximately 70% of patients had pain that lasted less than 2 days after treatment. Seventy-eight percent (36/46) of patients in the study were satisfied with treatment and would recommend it to others.


CONCLUSIONS
Patients felt bleomycin to be an effective treatment modality for warts, offering high rates of CR in lesions resistant to more traditional therapies.
Albert Einstein College of Medicine, Bronx, NY, USA.
Laura
L
Kruter
New York University Langone Medical Center, New York, NY, USA.
Vishal
V
Saggar
Albert Einstein College of Medicine, Bronx, NY, USA.
Alaleh
A
Akhavan
Albert Einstein College of Medicine, Bronx, NY, USA.
Parth
P
Patel
Albert Einstein College of Medicine, Bronx, NY, USA.
Nicole
N
Umanoff
Albert Einstein College of Medicine, Bronx, NY, USA.
Kate V
KV
Viola
Mount Sinai School of Medicine, New York, NY, USA.
William
W
Stebbins
Mount Sinai School of Medicine, New York, NY, USA.
Elizabeth
E
Smith
Mount Sinai School of Medicine, New York, NY, USA.
Arash
A
Akhavan
Albert Einstein College of Medicine, Bronx, NY, USA.
Justine V
JV
Cohen
Albert Einstein College of Medicine, Bronx, NY, USA steven.cohen@aya.yale.edu.
Steven R
SR
Cohen
D000293:Adolescent; D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage*; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy*; D006229:Hand Dermatoses / Q000188:drug therapy*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D012189:Retrospective Studies; D016896:Treatment Outcome; D014860:Warts / Q000188:drug therapy*; D055815:Young Adult
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin
bleomycin; dermatology; patient satisfaction; warts